Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.

Vyndaqel (tafamidis meglumine) - Pfizer

Amvuttra (vutrisiran) - Alnylam

http://www.ncbi.nlm.nih.gov/pubmed/42669069

Alisa Kosheleff; Amrut V Ambardekar; Arielle Abovich; Brian Claggett; Caroline Morbach; Francesco Cappelli; Julian D Gillmore; Marianna Fontana; Mathew S Maurer; Pablo Garcia-Pavia; Patrick Y Jay; Ronald M Witteles; Sameer Bansilal; Scott D Solomon

Aug 31, 2026